News

July 7, 2008 - OrbusNeich today said data recently presented at the 17th Annual Meeting of the Japanese Society of ...

Home July 06, 2008
Home
News

July 7, 2008 - InTouch Technologies Inc. today launched a new product feature, StrokeRESPOND, to extend the ...

Home July 06, 2008
Home
News

July 3, 2008 - A multicenter trial with up to five years of follow-up continues to support the mid- and long-term durability and safety of the Zenith endovascular graft used for aneurysm repair.

Home July 02, 2008
Home
Technology

Boston Scientific Corp. offers the PROMUS Everolimus-Eluting Coronary Stent System for the treatment of coronary artery disease. The PROMUS Stent is a private-labeled XIENCE V Everolimus-Eluting Coronary Stent System manufactured by Abbott and distributed by Boston Scientific under an agreement executed prior to the 2006 acquisition of the former Guidant Corp. by Boston Scientific.

Home July 02, 2008
Home
News

July 3, 2008 - A unanimous federal jury in Texas recently found that two patents exclusively licensed to Pressure Products Medical Supplies Inc., which cover medical products called valved peel-away introducers used for placement and implantation of pacemaker leads, were valid and infringed by the FlowGuard and ViaSeal products marketed by Quan Emerteq Corp.

Home July 02, 2008
Home
News

July 2, 2008 - The Society for Cardiovascular Angiography and Interventions (SCAI), the leading professional ...

Home July 01, 2008
Home
News

July 1, 2008 - The impact of surgeons' annual aortic volume and other prognostic indicators have been revealed in early outcomes of ruptured abdominal aortic aneurysm (RAAA) repair in a recent study from the University of Pittsburgh Medical Center. Details of the study have been published in the July issue of the Journal of Vascular Surgery.

Home July 01, 2008
Home
News

July 3, 2008 - Boston Scientific Corp. today said the FDA has approved the PROMUS Everolimus-Eluting Coronary Stent ...

Home July 01, 2008
Home
News

July 2, 2008 - The European Alliance for Access to Safe Medicines (EAASM) has today unveiled its comprehensive research report, “The Counterfeiting Superhighway,” which reveals that a frightening 62 percent of medicines purchased online are fake or substandard.

Home July 01, 2008
Home
News

July 1, 2008 - The FDA is asking healthcare professionals and facilities check all drug and device storage areas ...

Home June 30, 2008
Home
News

July 1, 2008 - CryoCath Technologies introduced the Arctic Front in Italy, Belgium and Spain, aiming to provide better ...

Home June 30, 2008
Home
News

July 1, 2008 - Toshiba Medical Systems Corp. (TMSC), the parent company of Toshiba America Medical Systems Inc ...

Home June 30, 2008
Home
News

July 1, 2008 - An interventional cardiology team this week led by Professor Patrick W. Serruys, M.D., Ph.D, successfully ...

Home June 30, 2008
Home
News

July 1, 2008 - American TeleCare Inc. (ATI) said today NuPhysicia LLC adopted ATI's CareTone Ultra digital stethoscope ...

Home June 30, 2008
Home
News

June 30, 2008 - Kimberly-Clark Health Care said today it received an agreement from Novation to offer its alliance ...

Home June 29, 2008
Home
Subscribe Now